Current aspects of adjuvant therapy of early stage ovarian cancer.
Early ovarian cancer, stages I and II, is a rare presentation of epithelial ovarian cancer for which adjuvant therapy may have some efficacy. More than two decades of studies are reviewed and conclusions offered. Additionally, important issues for the future therapy of this disease are presented.
McGuire
W P
WP
University of Mississippi School of Medicine, Atlanta, Ga., USA. Wmcguire52@aol.com
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy* / Q000601:surgery; D018714:Radiotherapy, Adjuvant; D016032:Randomized Controlled Trials as Topic; D015996:Survival Rate